William Blair & Company’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
William Blair & Company's MXCT Position: Q1 2026 in Review
William Blair & Company increased its MaxCyte (MXCT) stake by 0.12% in Q1 2026, buying an estimated $15 and bringing the position to 13,516 shares worth $9.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1835.
William Blair & Company first reported a position in MXCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.2M in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- William Blair & Company held 13,516 shares of MaxCyte worth $9.49K as of Q1 2026.
- William Blair & Company bought 16 MaxCyte shares in Q1 2026, an estimated $15.
- MaxCyte made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1835 holding.
- William Blair & Company first reported a position in MaxCyte in Q4 2021 and has held it in 18 quarters since.
- William Blair & Company's MaxCyte position peaked at $1.2M in Q4 2023.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.